U.S. Public Health Service HIV Counseling and Testing Recommendations for Pregnant Women

U.S. Public Health Service recommendations developed to address the increasing HIV epidemic among women and infants. The document stresses early diagnosis and is based on advances in treatment, including a clinical trial showing zidovudine reduced perinatal transmission risk by approximately two-thirds. Authored by the Centers for Disease Control and Prevention, it provides guidance for healthcare providers on routine counseling and voluntary testing.

Use Cases

• Analyzing public health policy evolution based on the described clinical trial evidence for zidovudine.
• Training NLP models to identify key recommendations in medical guideline documents.
• Studying the framing of voluntary testing and counseling protocols for at-risk populations.

Strengths

• Authored by the authoritative U.S. Centers for Disease Control and Prevention.
• Based on specific clinical trial evidence showing a two-thirds reduction in perinatal HIV transmission risk.
• Provides concrete guidance for healthcare providers on implementing counseling and testing programs.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

Centers for Disease Control and Prevention (U.S.)

Collection Method

Developed as formal public health recommendations.

Geography

United States